↓ Skip to main content

Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy

Overview of attention for article published in Advances in Therapy, July 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#12 of 2,494)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
42 news outlets
twitter
1 X user

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
7 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy
Published in
Advances in Therapy, July 2023
DOI 10.1007/s12325-023-02601-2
Pubmed ID
Authors

Jerome Goldschmidt, Lowell Hart, Jeffrey Scott, Kristen Boykin, Ray Bailey, Trevor Heritage, Lorena Lopez-Gonzalez, Zheng-Yi Zhou, Marie Louise Edwards, Alisha Monnette, Augustina Ogbonnaya, Kathryn Deyoung, Divea Venkatasetty, Ping Shi, Lindsay Aton, Huan Huang, Paul R. Conkling, Lucio Gordan

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 4 57%
Unknown 3 43%
Readers by discipline Count As %
Unspecified 4 57%
Unknown 3 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 302. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 August 2023.
All research outputs
#106,481
of 24,250,928 outputs
Outputs from Advances in Therapy
#12
of 2,494 outputs
Outputs of similar age
#1,212
of 220,267 outputs
Outputs of similar age from Advances in Therapy
#1
of 44 outputs
Altmetric has tracked 24,250,928 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,494 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.3. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 220,267 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.